Newlink Genetics reported $0 in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Bristol Myers Squibb BMY:US $ 39677M 2826M
Celldex Therapeutics CLDX:US $ 0M 0M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Idera Pharmaceuticals IDRA:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Prothena PRTA:US 0 0
Sarepta Therapeutics SRPT:US $ 1094.91M 1.93M
Vascular Biogenics VBLT:US 0 0
YTE INCY:US $ 31.38M 0.46M